Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Terumo pursues treatments for diabetes and complications

Sep. 6, 1996

Retinoid compound from Sparta enters U.S. clinical trials

Sep. 6, 1996

A new CETP inhibitor from Schering-Plough

Sep. 6, 1996

Japanese researchers describe natural lipid-lowering agents

Sep. 6, 1996

New agents for bone disorders from Banyu

Sep. 6, 1996

GRF(1-44) research alliance

Aug. 30, 1996

Merck & Co. reports on L-163689

Aug. 30, 1996

Aldose reductase/5-lipoxygenase inhibitors reported by Tsumura

Aug. 30, 1996

Aldose reductase inhibitors from Terumo

Aug. 30, 1996

Sankyo reports novel hypoglycemic agents

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 27, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...